In vivoanti-tumor activity of the organometallic ruthenium(ii)-arene complex Ru(η6-p-cymene)Cl2(pta) (RAPTA-C) in human ovarian and colorectal carcinomas | Synapse
January 1, 2014Open Access
In vivoanti-tumor activity of the organometallic ruthenium(ii)-arene complex Ru(η6-p-cymene)Cl2(pta) (RAPTA-C) in human ovarian and colorectal carcinomas
Key Points
Key points are not available for this paper at this time.
Abstract
Based on the clinical success of platinum-based anti-cancer drugs, a variety of other metal-based anti-cancer compounds are being investigated.